A Study of Occlu-tab for amblyopia treatment in India
Phase 4
Completed
- Conditions
- amblyopia
- Registration Number
- JPRN-UMIN000048104
- Lead Sponsor
- Japan International Cooporation Agency
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded if they had a history of amblyopia treatment, were diagnosed with strabismus, had difficulty in completing the visual acuity or refraction examination, or were receiving occlusion therapy by eye patch.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neuroplasticity mechanisms underlie binocular vision therapy in amblyopia treatment compared to monocular patching?
How does Occlu-tab's binocular approach compare to monocular patching in visual acuity outcomes for Indian children with amblyopia?
What biomarkers (e.g., visual evoked potentials, OCT metrics) predict response to binocular Occlu-tab in JPRN-UMIN000048104?
What are the adherence and compliance challenges in binocular vs monocular amblyopia therapies for pediatric populations in India?
Are there combination therapies involving Occlu-tab and pharmacological agents (e.g., donepezil, memantine) for amblyopia management?